Table 2 Distribution of SUA levels and hyperuricemia prevalence
Male | Female | p | Total | |
|---|---|---|---|---|
SUA (μmol/L) | ||||
Age groups | ||||
100–104 yrs | 379.18 ± 113.48 | 319.29 ± 89.34 | < 0.001 | 330.59 ± 97.16 |
105–109 yrs | 383.27 ± 92.75 | 311.11 ± 100.28 | < 0.001 | 323.41 ± 102.46 |
≥ 110 yrs | – | 321.39 ± 85.96 | 321.39 ± 85.96 | |
P | 0.853 | 0.606 | 0.615 | |
Total | 379.86 ± 110.08 | 317.91 ± 91.19 | 329.04 ± 97.75 | |
Hyperuricemia [n(%)] | ||||
Age groups | ||||
100–104 yrs | 42 (28.0) | 170 (26.4) | 0.682 | 212 (26.7) |
105–109 yrs | 12 (40.0) | 31 (21.2) | 0.059 | 43 (24.4) |
≥ 110 yrs | – | 11 (35.5) | – | 11 (35.5) |
P | 0.190 | 0.356 | 0.361 | |
Total | 54 (30.0) | 212 (25.8) | 0.247 | 266 (26.5) |